Company Earnings UpdateWalgreens Boots Alliance (NYSE: WBA) 2Q19 Results: Pricing and Reimbursement Pressures Hit Earnings; Company Lowers FY19 EPS Guidance Coresight Research April 3, 2019 Executive Summary Walgreens Boots Alliance reported 2Q19 revenues of $34.5 billion, in line with the consensus estimate and up 4.6% year over year. Diluted EPS came in at $1.24, down 8.8% year over year and below the consensus estimate of $1.50. Comps for the Retail Pharmacy USA business fell 3.8%, while Retail Pharmacy International comps decreased 1.4%. For FY19, Walgreens expects flat adjusted EPS, revised down from 7–12% growth. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: US Consumer and Retail Outlook—Holiday 2025 and Beyond: Premium Subscriber Call, September 2025Innovator Profile: PlayAbly—Creating Engaging, Branded Experiences with AI-Powered Shoppable GamesAgentic Commerce—The Impact on Retail Media and How Retailers Should RespondUS CPG Sales Tracker: E-Commerce Sales Surge, Outpacing In-Store Growth
